<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94097">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01917955</url>
  </required_header>
  <id_info>
    <org_study_id>CaMriSS_CSB</org_study_id>
    <secondary_id>EA4/073/10</secondary_id>
    <nct_id>NCT01917955</nct_id>
  </id_info>
  <brief_title>Cardiac MRI in Ischemic Stroke Study</brief_title>
  <acronym>CaMriSS</acronym>
  <official_title>Cardiac MRI in Ischemic Stroke Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Center for Stroke Research Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Neurology, Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cardiology and Angiology, Elisabeth Hospital, Essen, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <authority>Germany: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective single-center trial is to compare the safety and diagnostic
      value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal
      echocardiography in patients with acute ischemic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is
      safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of
      contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal
      echocardiography in patients with acute ischemic stroke.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke.</measure>
    <time_frame>&lt; 1 week after ischemic stroke</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of unrecognised myocardial infarction detected by late gadolinium-enhanced cardiac MRI in patients with acute ischemic stroke.</measure>
    <time_frame>&lt; 1 week after ischemic stroke</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">103</enrollment>
  <condition>Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Overall, 103 patients with acute ischemic stroke detected by brain magnetic resonance
        imaging will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute ischemic stroke detected by brain magnetic resonance imaging.

        Exclusion Criteria:

          -  Known atrial fibrillation or cardiac source of embolism

          -  Severe aphasia

          -  Acute infection or chronic inflammation

          -  Severe arteriosclerosis or stenosis of brain-supplying arteries

          -  Contraindications for magnetic resonance imaging or transesophageal echocardiography.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Matthias Endres, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Center for Stroke Research Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl Georg Haeusler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Stroke Research Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karl Georg Haeusler, MD</last_name>
    <phone>+49 30 8445 4244</phone>
    <email>georg.haeusler@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Georg Haeusler, MD</last_name>
      <phone>+49 30 8445 4244</phone>
      <email>georg.haeusler@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Kunze</last_name>
      <phone>49 30 8445 4118</phone>
      <email>c.kunze@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Karl Georg Haeusler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prof. Jochen B Fiebach, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PD Andreas Morguet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elisabeth Hospital</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Bruder, MD</last_name>
    </contact>
    <investigator>
      <last_name>Oliver Bruder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>August 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Karl Georg Haeusler</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
